When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FTSV - Forty Seven teams up with Rocket Pharma in rare pediatric anemia
Forty Seven Inc.
Forty Seven (FTSV-0.2%) will collaborate with Rocket Pharmaceuticals (RCKT-11.3%) to pursue proof-of-concept for the combination of its anti-cKIT antibody FSI-174, a conditioning regimen, and the latter's ex vivo lentiviral hematopoietic stem cell gene therapy RP-L102 in pediatric Fanconi Anemia (FA) patients.
More news on: Forty Seven, Inc., Rocket Pharmaceuticals, Inc., Healthcare stocks news,